BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23271316)

  • 1. Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice.
    van Groen T; Kadish I; Funke SA; Bartnik D; Willbold D
    J Alzheimers Dis; 2013; 34(3):609-20. PubMed ID: 23271316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with Aβ42 binding D-amino acid peptides reduce amyloid deposition and inflammation in APP/PS1 double transgenic mice.
    van Groen T; Kadish I; Funke A; Bartnik D; Willbold D
    Adv Protein Chem Struct Biol; 2012; 88():133-52. PubMed ID: 22814708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
    Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
    J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Optimized Combination of Ginger and Peony Root Effectively Inhibits Amyloid-β Accumulation and Amyloid-β-Mediated Pathology in AβPP/PS1 Double-Transgenic Mice.
    Lim S; Choi JG; Moon M; Kim HG; Lee W; Bak HR; Sung H; Park CH; Kim SY; Oh MS
    J Alzheimers Dis; 2016; 50(1):189-200. PubMed ID: 26639976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions.
    van Groen T; Liu L; Ikonen S; Kadish I
    Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506 reduces amyloid plaque burden and induces MMP-9 in AβPP/PS1 double transgenic mice.
    Hong HS; Hwang JY; Son SM; Kim YH; Moon M; Inhee MJ
    J Alzheimers Dis; 2010; 22(1):97-105. PubMed ID: 20847451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Naert G; Rivest S
    J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DL0410 can reverse cognitive impairment, synaptic loss and reduce plaque load in APP/PS1 transgenic mice.
    Yang RY; Zhao G; Wang DM; Pang XC; Wang SB; Fang JS; Li C; Liu AL; Wu S; Du GH
    Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):15-26. PubMed ID: 26476132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice.
    Liu L; Liu Y; Li N; Huang R; Zheng X; Huang L; Hou S; Yuan Q
    Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal TAT-haFGF Improves Cognition and Amyloid-β Pathology in an AβPP/PS1 Mouse Model of Alzheimer's Disease.
    Lou G; Zhang Q; Xiao F; Xiang Q; Su Z; Huang Y
    J Alzheimers Dis; 2016; 51(4):985-90. PubMed ID: 26890786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis.
    Xu G; Fromholt SE; Chakrabarty P; Zhu F; Liu X; Pace MC; Koh J; Golde TE; Levites Y; Lewis J; Borchelt DR
    Acta Neuropathol Commun; 2020 Apr; 8(1):43. PubMed ID: 32252825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice.
    Song Y; Cui T; Xie N; Zhang X; Qian Z; Liu J
    Int Immunopharmacol; 2014 May; 20(1):276-81. PubMed ID: 24667368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.
    Solberg NO; Chamberlin R; Vigil JR; Deck LM; Heidrich JE; Brown DC; Brady CI; Vander Jagt TA; Garwood M; Bisoffi M; Severns V; Vander Jagt DL; Sillerud LO
    J Alzheimers Dis; 2014; 40(1):191-212. PubMed ID: 24413613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice.
    Yu J; Gattoni-Celli M; Zhu H; Bhat NR; Sambamurti K; Gattoni-Celli S; Kindy MS
    J Alzheimers Dis; 2011; 25(2):295-307. PubMed ID: 21422528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice.
    Couch BA; Kerrisk ME; Kaufman AC; Nygaard HB; Strittmatter SM; Koleske AJ
    J Comp Neurol; 2013 Apr; 521(6):1395-408. PubMed ID: 23047754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.
    Magga J; Puli L; Pihlaja R; Kanninen K; Neulamaa S; Malm T; Härtig W; Grosche J; Goldsteins G; Tanila H; Koistinaho J; Koistinaho M
    J Neuroinflammation; 2010 Dec; 7():90. PubMed ID: 21138577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.